These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 8613375)

  • 1. A Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies protect mice against bacterial challenge.
    Fattom AI; Sarwar J; Ortiz A; Naso R
    Infect Immun; 1996 May; 64(5):1659-65. PubMed ID: 8613375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of capsular polysaccharide (CP) types of Staphylococcus aureus isolated from bovine mastitic milk and protection of S. aureus infection in mice with CP vaccine.
    Han HR; Pak S; Guidry A
    J Vet Med Sci; 2000 Dec; 62(12):1331-3. PubMed ID: 11193354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective efficacy of antibodies to the Staphylococcus aureus type 5 capsular polysaccharide in a modified model of endocarditis in rats.
    Lee JC; Park JS; Shepherd SE; Carey V; Fattom A
    Infect Immun; 1997 Oct; 65(10):4146-51. PubMed ID: 9317020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to capsular polysaccharides are not protective against experimental Staphylococcus aureus endocarditis.
    Nemeth J; Lee JC
    Infect Immun; 1995 Feb; 63(2):375-80. PubMed ID: 7821999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to Staphylococcus aureus capsular polysaccharides 5 and 8 perform similarly in vitro but are functionally distinct in vivo.
    Liu B; Park S; Thompson CD; Li X; Lee JC
    Virulence; 2017 Aug; 8(6):859-874. PubMed ID: 27936346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of serotypes 5 and 8 capsular polysaccharides in protection against Staphylococcus aureus in murine models of infection.
    Cheng BL; Nielsen TB; Pantapalangkoor P; Zhao F; Lee JC; Montgomery CP; Luna B; Spellberg B; Daum RS
    Hum Vaccin Immunother; 2017 Jul; 13(7):1609-1614. PubMed ID: 28422567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to Staphylococcus aureus serotype 8 capsular polysaccharide react with and protect against serotype 5 and 8 isolates.
    Park S; Gerber S; Lee JC
    Infect Immun; 2014 Dec; 82(12):5049-55. PubMed ID: 25245803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory and clinical evaluation of conjugate vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides bound to Pseudomonas aeruginosa recombinant exoprotein A.
    Fattom A; Schneerson R; Watson DC; Karakawa WW; Fitzgerald D; Pastan I; Li X; Shiloach J; Bryla DA; Robbins JB
    Infect Immun; 1993 Mar; 61(3):1023-32. PubMed ID: 8432585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clearance of Staphylococcus aureus from
    Harro JM; Achermann Y; Freiberg JA; Allison DL; Brao KJ; Marinos DP; Sanjari S; Leid JG; Shirtliff ME
    Infect Immun; 2019 Dec; 88(1):. PubMed ID: 31712267
    [No Abstract]   [Full Text] [Related]  

  • 10. Purified capsular polysaccharide-induced immunity to Staphylococcus aureus infection.
    Lee JC; Perez NE; Hopkins CA; Pier GB
    J Infect Dis; 1988 Apr; 157(4):723-30. PubMed ID: 3346565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of alpha-toxin, capsular polysaccharide (CPS) and recombinant fibronectin-binding protein (r-FnBP) of Staphylococcus aureus in rabbit.
    Park HM; Yoo HS; Oh TH; Kim D; Han HR
    J Vet Med Sci; 1999 Sep; 61(9):995-1000. PubMed ID: 10535504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and preclinical evaluation of two novel Staphylococcus aureus capsular polysaccharide 5 and 8-fusion protein (Hla-MntC-SACOL0723) immunoconjugates.
    Ahmadi K; Aslani MM; Pouladfar G; Faezi S; Kalani M; Pourmand MR; Ghaedi T; Havaei SA; Mahdavi M
    IUBMB Life; 2020 Feb; 72(2):226-236. PubMed ID: 31573748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and immunologic properties in mice of vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides conjugated to Pseudomonas aeruginosa exotoxin A.
    Fattom A; Schneerson R; Szu SC; Vann WF; Shiloach J; Karakawa WW; Robbins JB
    Infect Immun; 1990 Jul; 58(7):2367-74. PubMed ID: 2114365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural antibodies in normal human serum inhibit Staphylococcus aureus capsular polysaccharide vaccine efficacy.
    Skurnik D; Kropec A; Roux D; Theilacker C; Huebner J; Pier GB
    Clin Infect Dis; 2012 Nov; 55(9):1188-97. PubMed ID: 22806596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and characterization of a Staphylococcus aureus capsular polysaccharide-protein conjugate prepared by a low cost technique: a proof-of-concept study.
    Pujato N; Díaz G; Barbagelata MS; Vicco MH; Calvinho LF; Marcipar IS
    Appl Biochem Biotechnol; 2015 Jan; 175(1):141-54. PubMed ID: 25245681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. O-Acetylation is essential for functional antibody generation against Staphylococcus aureus capsular polysaccharide.
    Scully IL; Pavliak V; Timofeyeva Y; Liu Y; Singer C; Anderson AS
    Hum Vaccin Immunother; 2018 Jan; 14(1):81-84. PubMed ID: 29182428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of a conjugate vaccine composed of Staphylococcus aureus poly-N-acetyl-glucosamine and clumping factor A.
    Maira-Litrán T; Bentancor LV; Bozkurt-Guzel C; O'Malley JM; Cywes-Bentley C; Pier GB
    PLoS One; 2012; 7(9):e43813. PubMed ID: 22970144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis.
    Shinefield H; Black S; Fattom A; Horwith G; Rasgon S; Ordonez J; Yeoh H; Law D; Robbins JB; Schneerson R; Muenz L; Fuller S; Johnson J; Fireman B; Alcorn H; Naso R
    N Engl J Med; 2002 Feb; 346(7):491-6. PubMed ID: 11844850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to capsular polysaccharide and clumping factor A prevent mastitis and the emergence of unencapsulated and small-colony variants of Staphylococcus aureus in mice.
    Tuchscherr LP; Buzzola FR; Alvarez LP; Lee JC; Sordelli DO
    Infect Immun; 2008 Dec; 76(12):5738-44. PubMed ID: 18809660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective opsonic activity of antibodies against fibronectin-binding proteins (FnBPs) of Staphylococcus aureus.
    Rozalska B; Wadström T
    Scand J Immunol; 1993 May; 37(5):575-80. PubMed ID: 8484103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.